Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04652180

Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .

Led by Hospital Universitari de Bellvitge · Updated on 2023-03-01

108

Participants Needed

1

Research Sites

320 weeks

Total Duration

On this page

Sponsors

H

Hospital Universitari de Bellvitge

Lead Sponsor

U

University of Barcelona

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a randomized controlled trial designed to compare robot-assisted thoracic approach with open transthoracic esophagectomy (Ivor Lewis technique) as a surgical treatment for resectable esophageal cancer. If our hypothesis is proved correct, robot-assisted thoracic approach will result in a lower percentage of respiratory and overall postoperative complications, lower blood loss, shorter hospital stay, but with at least similar oncologic outcomes and better postoperative quality of life compared with the open transthoracic esophagectomy (current standard).

CONDITIONS

Official Title

Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Histologically confirmed adenocarcinoma, squamous cell carcinoma, undifferentiated carcinoma, or carcinoma of the gastro-esophageal junction (Siewert I or II)
  • Tumor is surgically resectable (T1-4a, N0-3, M0)
  • For women of childbearing potential, a negative pregnancy test is required
  • Signed informed consent provided
Not Eligible

You will not qualify if you...

  • Stage IV esophageal cancer or gastro-esophageal junction Siewert III cancer
  • Contraindication for transthoracic esophagectomy involving two fields
  • Presence of other cancers or conditions interfering with the study, such as prior thoracic surgery or trauma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain, 08907.

Actively Recruiting

Loading map...

Research Team

N

Natàlia Cornellà, Surgeon

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here